Natixis Advisors LLC Buys 270,476 Shares of The Cooper Companies, Inc. $COO
Natixis Advisors LLC increased its stake in The Cooper Companies by buying 270,476 shares in Q4, bringing holdings to 303,456 shares, according to its latest SEC 13F. The position was valued at about $24.9M (~0.15%). Separately, the article notes Cooper’s fiscal Q2 EPS of $1.21 (vs $1.10 consensus) and revenue of $1.08B, plus FY2026 EPS guidance of $4.58–$4.66.
How this was made
The 30-second read
Why it matters
COO’s reported EPS and revenue beat plus reaffirmed FY2026 EPS range provide fundamental support, while the outsized 13F increase can influence incremental demand/positioning signals.
Market read
Traders may treat this as a sentiment/positioning tailwind: ownership signals improved interest while earnings/guidance were supportive but not a major upside surprise.
What to watch
The article doesn’t quantify whether the 13F buying is incremental conviction or rebalancing; also, multiple analyst targets cluster around the mid-$80s, which may already be priced.
Background
The brief cites Natixis Advisors’ 13F filing showing a large stake increase in Cooper Companies and summarizes COO’s most recent fiscal second-quarter results and FY2026 EPS guidance.
Ticker impact
Natixis Advisors reported a large 13F stake increase in Cooper Companies, alongside the article’s recap of COO’s latest EPS beat and FY2026 guidance.
Bias modestly upward for the next few sessions, but upside may be capped if guidance is viewed as only in-line.
The article provides concrete ownership-change data (13F) and specific earnings/guidance figures; however, it’s still a recap-style news brief rather than a fresh earnings release or new guidance revision.
Market effects
Reinforces positive sentiment for medical device/vision care names, though the story is single-company focused.
No clear regional spillover beyond US healthcare/medical devices.
Limited; Cooper is global, but no international regulatory or competitive event is cited.
Counterpoint
The guidance range is close to consensus, so the institutional buying may reflect positioning rather than a new fundamental upside catalyst.
Key entities
- institutional investorNatixis Advisors LLC
Reported a large 13F stake increase in Cooper Companies during the 4th quarter.
- issuerCooper Companies, Inc.
Reported fiscal second-quarter EPS/revenue beats and reaffirmed FY2026 EPS guidance; subject of the ownership and analyst-target discussion.
